SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today that its Development and Commercialization Agreement with Dexcom, Inc., has been expanded to include ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps will ...

The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom (NASDAQ: DXCM), a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new ...

New products in development with partners Johnson & Johnson and Tandem could help Dexcom outmaneuver its chief competitor, Medtronic. More than 365 million people have diabetes worldwide and estimates ...

DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...

DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom The FDA has expanded use of Dexcom G4 Platinum (Pediatric), a continuous glucose monitoring (CGM) device, for children ages 2-17 years with ...

Dexcom ($DXCM) won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the ...

Dexcom Share, a cradle device that will allow users to send data from a Dexcom continuous glucose monitor to multiple smartphones, has received 510(k) clearance from the FDA. The system is designed to ...

As med tech outfits race to develop innovative, noninvasive technology for diabetes monitoring, Dexcom ($DXCM) snagged FDA approval for a new artificial pancreas ...

The future is closer than you think, at least in medical devices. I remember as a kid watching a science fiction movie where the patient was lying in a room and the doctor walked in, waved a device ...